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Water Dynamics at Protein-Protein Interface: Molecular Dynamic Study
of Virus-Host Receptor Complexes
Priyanka Dutta, Dr. Sameer Varma.
University of South Florida, Tampa, FL, USA.
The dynamical properties of water in the condensed phase deviate from their
bulk values at interfaces. Here we utilize all atom molecular dynamics (MD)
simulations to characterize the dynamical properties of water present in
protein-protein interfaces. We consider specifically the complexes formed be-
tween the attachment protein of the Nipah virus (G) and its preferred human
receptors, ephrins B2 and B3. These protein-protein interactions constitute the
first step in viral infection. X-ray diffraction of these two complexes indicates
an exceptionally large amount of water crystallized in the interstitial region
between the two proteins, as compared to other protein-protein complexes.
Surprisingly despite a modest sequence identity of ~50% between the two
ephrin receptors, the dynamical properties of water in the two complexes
are qualitatively similar. Specifically, we find that the diffusion coefficients
of interstitial waters are an order to magnitude smaller than those in bulk wa-
ter. Nevertheless, while the water molecules in the interstitial region show a
tendency to occupy their crystallographic positions, their residence times in
the interstitial region are of the order of only a few hundred picoseconds.
The water molecules in the interstitial region exchange with the bulk solvent,
and only a tiny fraction (< 5%) remain trapped in the interstitial region for
more than 150 ns. In spite of the perpetual exchange with bulk media, the
interstitial waters exhibit dipole relaxation rates and hydrogen bond lifetimes
several orders in magnitude greater than bulk water. The waters in these two
interfaces, in fact, carry a statistically large dipole moment perpendicular to
the interface, which is perhaps in response to the multiple salt bridges present
in the interface. Such deviations of water properties from bulk values are
significantly different from those observed at lipid-water and protein-water
interfaces.
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A Non-Active Site Set Domain Surface that is Crucial for Di-Methylation
of Histone H3 Lysine 4 by the Mixed Lineage Leukemia-1 (MLL1) Core
Complex
Stephen A. Shinsky1, Michael Hu2, Valarie E. Vought3,
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Histone 3 (H3) lysine 4 (H3K4) methylation is an evolutionary conserved
epigenetic mark that is involved in the control of gene expression. Lysine res-
idues can be mono-, di-, or tri-methylated, often which each mark leading to
different outcomes. In humans, the Mixed Lineage Leukemia-1 enzyme
(MLL1, ALL1, HRX, KMT2A) is a SET1 family member that possesses
H3K4 mono-methyltransferase activity conferred by its conserved Suppressor
of Variegation, Enhancer of Zest, Trithorax (SET) domain. Di-methylation of
H3K4 requires a sub-complex of proteins including WDR5, RbBP5, Ash2L,
and DPY-30 (WRAD), which binds to MLL1 forming the MLL1 core complex.
Di-methylation of H3K4 is associated with active transcriptional states of chro-
matin. We recently demonstrated that WRAD is a novel non-SET domain
enzyme that catalyzes H3K4 di-methylation in a manner that is dependent on
a non-active site surface from MLL1. The MLL1 surface required for interac-
tion with WRAD and for H3K4 di-methylation is unknown. Genome
sequencing studies recently revealed several missense mutations that occur in
and around the SET domain in various cancers and developmental disorders.
We noticed that a subset of missense mutations associated with human Kabuki
syndrome (KS) map to a common non-active site surface in the MLL1 SET
domain with no known function. In this investigation, we substituted all KS
missense amino acid positions into MLL1 and observed that all are required
for H3K4 di-methylation by the MLL1 core complex, which is associated
with a loss of the ability of MLL1 to interact with the RbBP5-Ash2L hetero-
dimer. Our results suggest that amino acids from this surface, called the Kabuki
interaction surface or (KIS), are required for formation of the H3K4 di-
methyltransferase active site within the MLL1 core complex.
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Identification of Protein-Protein-Interaction (PPI) Inhibitors and Stabi-
lizers for Antimalarial Drug Development using SPR
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1Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg
School of Public Health, Baltimore, MD, USA, 2Johns Hopkins Malaria
Research Institute, Baltimore, MD, USA.Malaria has been a human life threat for centuries, particularly in tropical and
subtropical regions of the world. Nevertheless, our repertoire of medication to
treat the disease has been very limited 1, and emerging resistance of the ma-
laria parasite Plasmodium has further restricted the use of current antimalarial
treatment. The most recent reports indicating artemisinin resistance in
Cambodia2 are indeed alarming and underscore the critical importance of
exploring novel pathways for interfering with the life cycle of the malaria
parasite.
Surface plasmon resonance (SPR) has been a powerful tool to study protein
ligand interactions. We utilize this technique for fragment and small
molecule screening (~150-500 Da) to identify PPI-inhibitors or PPI-
stabilizers 3.
In this study we present the identification of PPI-inhibitors for three plasmodial
targets and two examples of PPI-stabilizers. We will furthermore demonstrate
the in vitro effect on Plasmodium falciparum cultures of these PPI-inhibitors
and PPI-stabilizers in the liver stage as well as blood stage form of the parasite.
Small-molecules derived from our studies may represent useful probes for
further dissecting the underlying biological mechanisms and analyzing the
pathways in Plasmodium and other apicomplexan species such as Toxoplasma,
Cryptosporidium, Eimeria, Theileria and Babesia. Further development of our
current small molecules may provide initial hits for lead optimization in drug
design studies.
References
1 Baird, J. K. Effectiveness of antimalarial drugs. N Engl J Med 352, 1565-
1577, doi:10.1056/NEJMra043207 (2005).
2 Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium
falciparum in Cambodia. Nat Genet 45, 648-655, doi:10.1038/ng.2624 (2013).
3 Boucher, L. E. & Bosch, J. Development of a multifunctional tool for drug
screening against Plasmodial protein-protein interactions via Surface Plasmon
Resonance. Journal of Molecular Recognition 26, 496-500 (2013).
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NewMicrocalorimetric Methods for Measuring Ultratight Protein-Ligand
Interactions
Georg Krainer, Jana Broecker, Carolyn Vargas, Sandro Keller.
TU Kaiserslautern, Kaiserslautern, Germany.
Isothermal titration calorimetry (ITC) is the gold standard for the quantitative
characterization of biomolecular interactions. However, reliable determination
of the dissociation constant (KD) is typically limited to the range 100 mM >
KD > 1 nM. Nevertheless, interactions characterized by a higher KD can be as-
sessed indirectly, provided that a suitable competitive ligand is available whose
KD falls within the directly accessible window. Unfortunately, the established
competitive ITC displacement method has two major limitations. First, it re-
quires the high-affinity ligand be soluble at high concentrations in aqueous
solution (typically >100 mM). This poses serious problems in quantifying
high-affinity interactions involving poorly water-soluble small-molecule li-
gands taken from compound libraries, as is usually the case in many drug-
discovery projects. A second limitation of the displacement method is that
the protocol necessitates at least two titrations to characterize one high-
affinity inhibitor. This limits the great potential of microcalorimetry both in
drug discovery efforts, where high sample throughput is required, as well as
in basic research, where precious biological samples are often available only
in limited amounts.
Here, we present two novel competition assays for measuring ultratight protein-
ligand interactions by ITC that overcome these limitations. The first assay al-
lows for a precise thermodynamic description of high-affinity protein-ligand in-
teractions involving poorly water-soluble compounds (Krainer et al. Anal.
Chem.2012, 84, 10715), while the second assay provides a simultaneous quan-
tification of both the competitive, moderate-affinity and the high-affinity ligand
in a single experiment with minimal sample requirement. We discuss the theo-
retical background of the approach and demonstrate some practical applications
using examples of high-affinity protein-ligand interactions.
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tive Molecules: Photothermal Studies of Ligand Release
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The thermodynamics associated with small-protein interactions essentially
define how drugs bind to target receptor proteins. As proteins are dynamic,
it is of importance to understand the early time (sub-millisecond) thermody-
namics and kinetics associated with small molecules binding. This time
regime presents experimental challenges in both the measurement of the
478a Tuesday, February 18, 2014thermodynamics as well as in the introduction of the small molecule ligands
on fast time scales. An attractive strategy is to ‘cage’ the protein ligand with
a photochemically cleavable protecting grou which, upon photolysis, releases
the ligand on nanosecond timescales allowing for the examination of fast
time dynamics associated with ligand-protein interactions. Here, a new class
of photocage is presented based upon the photophysics of Ru(II)bis
(2,20bipyridine)L2 type complexes. Specifically, we present the thermody-
namics of ligand photodetachment from both Ru(II)bis(2,20-bipyridine)(ace-
tonitrile)2, Ru(II)bis(2,2
0-bipyridine)(6,60-dimethyl-2,20-bipyridine), Ru(II)
bis(2,20-bipyridine)(seratonin)2 and Ru(II)bis(2,20-bipyridine)(tyramine)2
complexes in aqueous solution using photoacousctic calorimetry (PAC) and
density functional theory. Our results are consistent with N donation
form the ligands to the metal dominating the interaction energies and posi-
tive reaction entahlpies. In addition, the relative small changes in molar vol-
ume change suggest the each complex is highly solvated in aqueous
solutions.
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‘‘The Whole is Greater than the Sum of Its Parts-’’ Hit Selection and the Po-
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Biophysical methods are essential tools in current front line drug discovery pro-
cesses. They can be used for optimization of protein constructs and verification
of proper and consistent protein folding, identification of optimal assay buffer,
screening of fragments and the confirmation of binding to the right or allosteric
binding site(s) of the target molecule- each approach providing a wealth of in-
formation. With a growing industry need to reduce project attrition (and there-
fore cost) by providing more physiological mechanistic data to aid in the
identification of compounds that translate in vitro activity into in vivo efficacy.
Application of panels of biophysical techniques allow cross correlation of data
and better control of experimental parameters - increasing reliability and con-
fidence in results whilst eliminating artifacts. In this work we show how SPR,
DSC and ITC can be used in the selection and verification of binders in a Frag-
ment Based Drug Discovery campaign by providing quantitative binding infor-
mation to advance true hits for chemistry and later stage biology in hit to lead
development.
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thetic Targets
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of Pennsylvania, Philadelphia, PA, USA.
Propofol, a dialkylphenol intravenous anesthetic, has been widely administered
for over a quarter century in general anesthesia and for rapid sedation. Regard-
less, the drug’s mechanism of action remains elusive with mounting evidence
suggesting contributions from multiple pathways. Most proposed targets, such
as ion channels and ligand gated receptors, are low abundance but functionally
important proteins. To uncover these significant targets, we synthesized a pho-
toactive- and ‘clickable’- propofol analogue with meta-trifluoromethyldiazir-
inyl and ortho-(propynyloxy)methyl substitutions in place of the two
isopropyl groups. This novel o-alkynyl-m-azipropofol maintains the physio-
chemical, biochemical and in vivo properties of propofol. It also photoadducts
to known propofol binding sites in model proteins. Once adducted, the alkyne
click moiety successfully undergoes copper catalyzed 1,3-dipolar cycloaddi-
tion reactions with azide-rodamine and -biotin tags allowing for fluorescent la-
beling and avidin resin enrichment of photolabeled targets within ex vivo
systems. Using fluorescent microscopy or mass spectroscopy, the chemically
‘dual-active’ propofol analogue allows localization and identification of key
targets in the biochemical pathways that underlie alkylphenol induced
anesthesia.
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Exploring Anesthetic Binding on Voltage-Gated Cation Channels
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Thomas Jefferson University, Philadelphia, PA, USA.A multi-dimensional docking analysis was applied to investigate the binding
of general anesthetics against distinct channel isoforms and conformations.
Specifically, MD-generated ensembles of the channel isoforms K-Shaw2,
Kv1.2 and Kv1.2-G329T in the activated-open and resting-closed conforma-
tions were docked against a family of anesthetic chemotypes, composed by
halothane, isoflurane, sevoflurane and propofol. The total 240,000 docking
solutions bind the channel structures at multiple sites split over four major
regions (voltage-sensor, S4-S5 linker, selectivity filter and central cavity)
within a diverse range of binding affinities Kb, ie., 2-50 mM. We followed
a subtraction analysis to resolve channel and conformation dependency of
ligand affinity on each binding site. From the analysis, sites placed at the
S4-S5 linker and at the selectivity filter arise for every ligand as putative re-
gions accounting for differential binding over channel variants and confor-
mations. Although useful to identify sites potentially associated with
differential binding of anesthetics across distinct conformations and isoforms,
the present estimates for binding affinities as provided by Autodock Vina are
largely approximative, thereby limiting concrete connections between the
data and experimental measurements. To circumvent this difficulty, we
have started a long series of FEP calculations to evaluate the binding affinity
of sevoflurane and isoflurane against K-Shaw2 and Kv1.2 in both their
activated-open and resting-closed states. The FEP computations carried so
far have confirmed the differences between conformation affinities on the
S4-S5 linker region for the Kv1.2 isoform. Taken together, our results reveal
binding sites that may underlie channel specific effects of general anesthetics
providing thus new directions for further experimental investigation of this
topic.
2418-Pos Board B110
Nudt9H Interactions in the Tetrameric TRPM2 Ion Channel
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TRPM2 is a Ca2þ-permeable cation channel that belongs to the M subfamily of
Transient Receptor Potential (TRP) channel proteins. TRPM2 is a homote-
tramer, each monomer contains a cytosolic N-terminal TRPM-homology re-
gion, six transmembrane helices with an architecture typical to that of
voltage-gated cation channels, and a cytosolic coiled-coil region followed by
a NUDT9-Homology (NUDT9H) domain at the C-terminus.
TRPM2 activates in the presence of Ca2þ, ADP-Ribose (ADPR), and PIP2
(Toth and Csanady, 2012). ADPR binds to the NUDT9H-domain which dis-
plays ~35% identity with NUDT9, a monomeric mitochondrial ADPR-
pyrophosphatase with available crystal structure (Shen et al., 2003). At pre-
sent, it is unclear whether NUDT9H is an active enzyme itself, or just an
ADPR-binding domain. In contrast to the extremely high solubility of
NUDT9, NUDT9H solubility is very low: when overexpressed in bacterial
systems it forms inclusion bodies, and reprecipitates upon removal of chaot-
ropic agents. This might be a consequence of the tetrameric nature of
TRPM2, in the context of which it is unclear how the four N-terminal domains
and the four NUDT9H domains interact with each other and/or with the trans-
membrane segments. The fact that ADPR binding to NUDT9H is necessary
for channel activation suggests an extended interface between NUDT9H and
some partnering segment within the complex. Surface exposure of this inter-
face region may account for the reduced solubility of NUDT9H when ex-
pressed in isolation.
Here we explore this hypothesis by expressing soluble NUDT9, insoluble
NUDT9H, as well as different NUDT9/NUDT9H chimeras. By monitoring
the solubility of the chimeras, we attempt to narrow down the search for the
functional interface of NUDT9H. In addition, we try to identify the minimal
substitutions required for increasing NUDT9H solubility. Finally, we use solu-
ble NUDT9 to test hydrolysis of various substrates/ligands that activate the
TRPM2 channel.
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Mapping of Netrin-1 Binding to its Dependence Receptors
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Netrin-1 is a bifunctional guidance cue for migrating axons in vertebrates. De-
pending on the target receptor family netrin-1 interacts with, it either causes
attraction or repulsion of axonal growth cones. Chemoattraction is mediated
by adhering to DCC or its homologue neogenin, whereas chemorepulsion
